Related references
Note: Only part of the references are listed.Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning
Shannon R. McCurdy et al.
BLOOD (2022)
Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies
Julie Preillon et al.
MOLECULAR CANCER THERAPEUTICS (2021)
BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells
Chen Yao et al.
NATURE IMMUNOLOGY (2021)
Integrated analysis of multimodal single-cell data
Yuhan Hao et al.
CELL (2021)
Optimized Timing of Post-Transplantation Cyclophosphamide in MHC-Haploidentical Murine Hematopoietic Cell Transplantation
Lucas P. Wachsmuth et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation
Pier Edoardo Rovatti et al.
FRONTIERS IN IMMUNOLOGY (2020)
NKcell alloreactivity in acute myeloid leukemia in the post-transplant cyclophosphamide era
Catharina H. M. J. Van Elssen et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
Ting Zhou et al.
NATURE (2020)
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells
Matthias Braun et al.
IMMUNITY (2020)
T cell exhaustion and a failure in antigen presentation drive resistance to the graft-versus-leukemia effect
Meng Zhou et al.
NATURE COMMUNICATIONS (2020)
glmGamPoi: fitting Gamma-Poisson generalized linear models on single cell count data
Constantin Ahlmann-Eltze et al.
BIOINFORMATICS (2020)
Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation
Daniela Pais Ferreira et al.
IMMUNITY (2020)
Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation
Awais Ijaz et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction
Xindong Liu et al.
NATURE (2019)
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
Maddalena Noviello et al.
NATURE COMMUNICATIONS (2019)
Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression
Lucas P. Wachsmuth et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study
Radhakrishnan Ramchandren et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
TOX is a critical regulator of tumour-specific T cell differentiation
Andrew C. Scott et al.
NATURE (2019)
Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation
Federico Simonetta et al.
FRONTIERS IN IMMUNOLOGY (2019)
Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma
Lei Wu et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT
Eolia Brissot et al.
HAEMATOLOGICA (2019)
Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
Imran Siddiqui et al.
IMMUNITY (2019)
Bone marrow transplantation generates T cell-dependent control of myeloma in mice
Slavica Vuckovic et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection
William H. Hudson et al.
IMMUNITY (2019)
Defining 'T cell exhaustion'
Christian U. Blank et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
Armin Rashidi et al.
BLOOD ADVANCES (2019)
Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model
Camille Guillerey et al.
JCI INSIGHT (2019)
Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression
Christoph Hafemeister et al.
GENOME BIOLOGY (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8+ T Cells During Relapse after Allogeneic Stem Cell Transplantation
Tim J. A. Hutten et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017
Xuejiao Yin et al.
CANCER CELL INTERNATIONAL (2018)
Flt-3L Expansion of Recipient CD8α+ Dendritic Cells Deletes Alloreactive Donor T Cells and Represents an Alternative to Posttransplant Cyclophosphamide for the Prevention of GVHD
Kate A. Markey et al.
CLINICAL CANCER RESEARCH (2018)
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
Margaretha G. M. Roemer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
Philippe Armand et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms
Alessandro Prestipino et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade
Simone A. Minnie et al.
BLOOD (2018)
Targeting the PD-1/PD-L1 axis in multiple myeloma: a dream or a reality?
Jacalyn Rosenblatt et al.
BLOOD (2017)
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
Shannon R. McCurdy et al.
HAEMATOLOGICA (2017)
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
Shannon R. McCurdy et al.
HAEMATOLOGICA (2017)
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang et al.
NATURE (2017)
Chromatin states define tumour-specific T cell dysfunction and reprogramming
Mary Philip et al.
NATURE (2017)
chromVAR : inferring transcription-factor-associated accessibility from single-cell epigenomic data
Alicia N. Schep et al.
NATURE METHODS (2017)
Peripheral human CD4+CD8+ T lymphocytes exhibit a memory phenotype and enhanced responses to IL-2, IL-7 and IL-15
Marie-Laure Clenet et al.
SCIENTIFIC REPORTS (2017)
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation
Stefan O. Ciurea et al.
BLOOD (2017)
PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
Bradley M. Haverkos et al.
BLOOD (2017)
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
Charles Herbaux et al.
BLOOD (2017)
T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy
David J. Chung et al.
CANCER IMMUNOLOGY RESEARCH (2016)
T cells in multiple myeloma display features of exhaustion and senescence at the tumor site
Claudia Zelle-Rieser et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1
Mariko Ishibashi et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Stefan O. Ciurea et al.
BLOOD (2015)
Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation
Alessandra Roberto et al.
BLOOD (2015)
FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data
Sofie Van Gassen et al.
CYTOMETRY PART A (2015)
The Transcription Factor NFAT Promotes Exhaustion of Activated CD8+ T Cells
Gustavo J. Martinez et al.
IMMUNITY (2015)
Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients
S. Yousef et al.
BLOOD CANCER JOURNAL (2015)
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma
Cinzia Fionda et al.
ONCOTARGET (2015)
Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma
Liang Wang et al.
ONCOTARGET (2015)
Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis
M. Stern et al.
LEUKEMIA (2014)
IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
Nicoletta Cieri et al.
BLOOD (2013)
Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality
Asim Saha et al.
BLOOD (2013)
Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy
Marta Chesi et al.
BLOOD (2012)
Identifying ChIP-seq enrichment using MACS
Jianxing Feng et al.
NATURE PROTOCOLS (2012)
Differential niche and Wnt requirements during acute myeloid leukemia progression
Steven W. Lane et al.
BLOOD (2011)
PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation
Wieger J. Norde et al.
CANCER RESEARCH (2011)
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
Nicole Joller et al.
JOURNAL OF IMMUNOLOGY (2011)
The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells
Erika Cretney et al.
NATURE IMMUNOLOGY (2011)
Soluble lymphotoxin is an important effector molecule in GVHD and GVL
Kate A. Markey et al.
BLOOD (2010)
Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells
Takashi Inozume et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Role of autologous and allogeneic stem cell transplantation in myeloma
W. I. Bensinger
LEUKEMIA (2009)
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
Xin Yu et al.
NATURE IMMUNOLOGY (2009)
Mesenchymal Stem Cells Remain Host-Derived Independent of the Source of the Stem-Cell Graft and Conditioning Regimen Used
Kristina Bartsch et al.
TRANSPLANTATION (2009)
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies
Marta Chesi et al.
CANCER CELL (2008)
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells
Yasser M. El-Sherbiny et al.
CANCER RESEARCH (2007)
CD28-mediated regulation of multiple myeloma cell proliferation and survival
Nizar J. Bahlis et al.
BLOOD (2007)
Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-γ-dependent mechanism
BR Blazar et al.
JOURNAL OF IMMUNOLOGY (2003)
Donor-derived interferon γ separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells
YG Yang et al.
BLOOD (2002)
Share Paper
